Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Contemporary surgical options in large benign prostatic hyperplasia treatment

Show simple item record

dc.contributor.author Pleșacov, Alexei
dc.contributor.author Vladanov, Ivan
dc.contributor.author Ghicavîi, Vitalii
dc.date.accessioned 2023-05-07T11:33:05Z
dc.date.available 2023-05-07T11:33:05Z
dc.date.issued 2022
dc.identifier.citation PLESACOV, Alexei, VLADANOV, Ivan, GHICAVÎI, Vitalii. Contemporary surgical options in large benign prostatic hyperplasia treatment. In: Revista de Științe ale Sănătății din Moldova = Moldovan Journal of Health Sciences. 2022, vol. 30(4), pp. 32-37. ISSN 2345-1467. https://doi.org/10.52645/MJHS.2022.4.06 en_US
dc.identifier.issn 2345-1467
dc.identifier.uri https://cercetare.usmf.md/sites/default/files/inline-files/REVISTA%20DE%20%C8%98TIIN%C8%9AE%20ALE%20S%C4%82N%C4%82T%C4%82%C8%9AII%20DIN%20MOLDOVA%20NR.%204%2C%202022_0.pdf
dc.identifier.uri https://doi.org/10.52645/MJHS.2022.4.06
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/24219
dc.description.abstract Abstract. Introduction. Specialists are currently interested in the method of choice for surgical treatment in patients with enlarged benign prostate hyperplasia (> 80 cm3 ). The introduction of laser and bipolar technologies for benign prostate hyperplasia surgery has allowed effective treatment regardless of the size of the prostate gland. Material and methods. During 2020-2021, 65 patients underwent surgical treatment for large benign prostate hyperplasia. Depending on the type of surgical treatment performed, 3 study groups were identified: 22 patients underwent transurethral Thulium: YAG laser prostate vapoenucleation; 21 patients underwent transurethral bipolar prostate enucleation; and 21 patients underwent a simple prostatectomy. All patients were examined before and after surgery (at 3 and 6 months) using the International Prostate Symptom Score, Quality of Life Score, prostate-specific antigen assessment, transrectal prostate ultrasound examination, and uroflowmetry to assess residual urine volume. Postoperative complications were recorded in accordance with the 2004 Clavien-Dindo classification. Results. There was a significant difference in the mean operative time ranging from 72±19 min (ThuVEP group) vs. 56±10 min (SP group) and 70±15 min (TUEB group), as well as a decrease in hemoglobin levels, viz. 1.2±0.4 g/dl vs. 2.6±1.1 g/dl vs. 1.6±0.5 g/dl (ThuVEP vs. SP vs. TUEB). The catheterization lasted for 2±1 days (ThuVEP) vs. 10±1 days (SP) vs. 3±1 days (TUEB). A significant improvement in Qmax was registered in the ThuVEP group (122.9%) and in the TUEB group (111.7%). However, patients after a simple prostatectomy showed an increase in Qmax of only 94%. The PVR values were reported to be the same. ThuVEP is an effective surgical technique for large BPH patients. The reduced trauma and lower complication rate of ThuVEP, as well as its effectiveness, have confirmed the need for widespread implementation of minimally invasive laser interventions. en_US
dc.language.iso en en_US
dc.publisher Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova en_US
dc.relation.ispartof Revista de Științe ale Sănătății din Moldova = Moldovan Journal of Health Sciences en_US
dc.subject laser en_US
dc.subject bipolar enucleation en_US
dc.subject prostate en_US
dc.subject.ddc UDC: 616.65-007.61-089 en_US
dc.title Contemporary surgical options in large benign prostatic hyperplasia treatment en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics